Medical Developments International | MVP - Net Income

Stock Price
0.45
Daily Change
-0.01 -2.17%
Monthly
-17.43%
Yearly
-43.75%
Q1 Forecast
0.46

Medical Developments International reported AUD-105K in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Alaunos Therapeutics USD -1.16M 417K Sep/2025
Avita Medical AUD -9.92M 1.67M Jun/2025
Clinuvel Pharmaceuticals AUD 24.7M 13.76M Jun/2024
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Genetic Signatures AUD -15.2M 7.81M Dec/2024
Ionis Pharmaceuticals USD -128.61M 252.16M Sep/2025
Medical Developments International AUD -105K 409K Jun/2025
Neuren Pharmaceuticals AUD 7.52M 126.51M Jun/2025
Organon & Co USD 160M 15M Sep/2025
Paradigm Biopharmaceuticals AUD -6.42M 495.95K Jun/2025
PYC Therapeutics AUD -12.37M 13.2M Jun/2025
Starpharma Holdings AUD -2.3M 3.09M Jun/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Telix Pharmaceuticals AUD 10.13M 19.52M Dec/2024
Viatris USD -128.2M 123.6M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025